Menu
The Parkinson’s – Alzheimer’s – Dementia panel is designed for individuals with a personal and/or family history of Parkinson’s disease, Alzheimer’s disease, or dementia to help establish or confirm a diagnosis, assess risks, and/or guide management. Recent studies have shown that approximately 10-15% of Parkinson’s disease cases can be attributed to a mutation in a single gene. Having a family history of one of these conditions may increase the risk of developing that condition. Genetic testing can also inform other family members (parents, siblings, and children) about their risk factors.
Your patient's health is your most important asset. You should entrust it only to the best professionals.
Due to our research findings and technology, we are able to provide timely reports of genetic and specialty testing.
All scientists and personnel at Genetics Institute of America have been trained thoroughly to assist in any situation.
Our panels are designed for steady progress, with every phase promptly implemented.
Speak to one of our representatives today to learn more about enrolling your practice.
Sign up to receive monthly updates on new product announcements, press releases, promotions, and more.
Speak to one of our representatives today to learn more about our CAP and CLIA-accredited laboratory.
Copyright © 2023 Genetics Institute of America. All Rights Reserved.